Role of MRD as Prognostic Indicator, Clinical Trial Endpoint for Multiple Myeloma
Year: 2019
Type: article
Source: Journal of Clinical Pathways
Author: C Ola Landgren
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2944802700